Boston Scientific
BOSTON SCIENTIFIC CORP
NYSE: BSX. Canonical company identity and public leadership record.
US
- Alpha ID
- alpha:company:c74e3454-c7a5-426f-b315-da986196b6e2
- SEC CIK
- 0000885725
- Website
- www.bostonscientific.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
- Newest evidence
- Mar 18, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Michael F. MahoneySince Mar 18, 2026
- Chair
- Not publishedLead independent: Eric Ludwig
- Independent
- 9 / 1010 directors published
- Published claims
- 464 distinct sources
- Evidence records
- 100 pinned
- Source conflicts
- 0None open
Built from 4 distinct sources and 10 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Arthur C. Butcher executive of Boston Scientific, effective 2026-03-18.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Executive Vice President and Group President, MedSurg and Asia Pacific | Arthur C. Butcher | Mar 2026 | current | Source reportedE4 |
| Executive Vice President and Chief Financial Officer | Jonathan R. Monson | Mar 2026 | current | Source reportedE5 |
| Executive Vice President and Group President, Cardiovascular | Joseph M. Fitzgerald | Mar 2026 | current | Source reportedE6 |
| Chairman of the Board, President and Chief Executive Officer | Michael F. Mahoney | Mar 2026 | current | Source reportedE7 |
| Executive Vice President, General Counsel and Corporate Secretary | Vance R. Brown | Mar 2026 | current | Source reportedE8 |
Board of directors
Evidence10 directors published. 9 of 10 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Cathy R. Smith | Independent | 2026 | AuditAudit; Nominating and GovernanceNominating and Governance | Source reportedE3 |
| Cheryl Pegus | Independent | 2024 | Executive Compensation and Human ResourcesExecutive Compensation and Human Resources; Risk, Science and Technology · ChairRisk, Science and Technology, chair | Source reportedE3 |
| Christophe P. Weber | Independent | 2026 | Executive Compensation and Human ResourcesExecutive Compensation and Human Resources; Risk, Science and TechnologyRisk, Science and Technology | Source reportedE3 |
| David C. Habiger | Independent | 2024 | AuditAudit; Executive Compensation and Human ResourcesExecutive Compensation and Human Resources | Source reportedE3 |
| David S. Wichmann | Independent | 2021 | Audit, chairAudit · Chair; Risk, Science and TechnologyRisk, Science and Technology | Source reportedE3 |
| Ellen M. Zane | Independent | 2016 | Executive Compensation and Human Resources, chairExecutive Compensation and Human Resources · Chair; Nominating and GovernanceNominating and Governance | Source reportedE3 |
| Eric Ludwig | IndependentLead Independent | 2014 | AuditAudit; Nominating and GovernanceNominating and Governance | Source reportedE3 |
| Jessica L. Mega | Independent | 2023 | Executive Compensation and Human ResourcesExecutive Compensation and Human Resources; Risk, Science and TechnologyRisk, Science and Technology | Source reportedE3 |
| Michael F. Mahoney | Not independent | 2012 | None published | Source reportedE3 |
| Susan E. Morano | Independent | 2023 | AuditAudit; Nominating and Governance · ChairNominating and Governance, chair | Source reportedE3 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | David S. Wichmann | David S. Wichmann, Cathy R. Smith, David C. Habiger, Eric Ludwig, Susan E. Morano | Not described in the published record |
| Audit · Chair; Risk, Science and Technology | Not published | David S. Wichmann | Not described in the published record |
| Audit; Executive Compensation and Human Resources | Not published | David C. Habiger | Not described in the published record |
| Audit; Nominating and Governance | Not published | Cathy R. Smith, Eric Ludwig | Not described in the published record |
| Audit; Nominating and Governance · Chair | Not published | Susan E. Morano | Not described in the published record |
| Executive Compensation and Human Resources | Ellen M. Zane | Ellen M. Zane, Cheryl Pegus, Christophe P. Weber, David C. Habiger, Jessica L. Mega | Not described in the published record |
| Executive Compensation and Human Resources · Chair; Nominating and Governance | Not published | Ellen M. Zane | Not described in the published record |
| Executive Compensation and Human Resources; Risk, Science and Technology | Not published | Christophe P. Weber, Jessica L. Mega | Not described in the published record |
| Executive Compensation and Human Resources; Risk, Science and Technology · Chair | Not published | Cheryl Pegus | Not described in the published record |
| Nominating and Governance | Susan E. Morano | Susan E. Morano, Cathy R. Smith, Ellen M. Zane, Eric Ludwig | Not described in the published record |
| Risk, Science and Technology | Cheryl Pegus | Cheryl Pegus, Christophe P. Weber, David S. Wichmann, Jessica L. Mega | Not described in the published record |
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
Evidence| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NYSE: BSX | current | Feb 24, 1995 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Arthur C. ButcherExecutive Vice President and Group President, MedSurg and Asia Pacificcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:19
- Jonathan R. MonsonExecutive Vice President and Chief Financial Officercompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:20
- Joseph M. FitzgeraldExecutive Vice President and Group President, Cardiovascularcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:21
- Michael F. MahoneyChairman of the Board, President and Chief Executive Officercompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:22, company:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:17
- Vance R. BrownExecutive Vice President, General Counsel and Corporate Secretarycompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:23
- Cathy R. SmithDirectorcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:9
- Cheryl PegusDirectorcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:10
- Christophe P. WeberDirectorcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:11
- David C. HabigerDirectorcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:12
- David S. WichmannDirectorcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:13
- Ellen M. ZaneDirectorcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:14
- Eric LudwigLead Independent Directorcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:15
- Jessica L. MegaDirectorcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:16
- Susan E. MoranoDirectorcompany:c74e3454-c7a5-426f-b315-da986196b6e2:leadership_role:18
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 10 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 6 Claims.
- E2BOSTON SCIENTIFIC CORP Form 10-K (filed 2026-02-17). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec proxy. Published Mar 18, 2026. Retrieved Mar 21, 2026. Cited by 10 Claims.
- E4sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E5sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E6sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E7sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E8sec filing. Published Mar 18, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E9board_seats. board seats. Cited by 22 Claims.
- E10Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026- Arthur C. Butcher executive of Boston Scientific, effective 2026-03-18.
- Jonathan R. Monson executive of Boston Scientific, effective 2026-03-18.
- Joseph M. Fitzgerald executive of Boston Scientific, effective 2026-03-18.
- Michael F. Mahoney executive of Boston Scientific, effective 2026-03-18.
- Vance R. Brown executive of Boston Scientific, effective 2026-03-18.
- Cathy R. Smith seat on Boston Scientific, effective 2026-01-01.
- Christophe P. Weber seat on Boston Scientific, effective 2026-01-01.
- Audit; Nominating and Governance committee of Boston Scientific, effective 2026-01-01.
- Cathy R. Smith member of Audit; Nominating and Governance, effective 2026-01-01.
- Executive Compensation and Human Resources; Risk, Science and Technology committee of Boston Scientific, effective 2026-01-01.
- Christophe P. Weber member of Executive Compensation and Human Resources; Risk, Science and Technology, effective 2026-01-01.
- Cheryl Pegus seat on Boston Scientific, effective 2024-01-01.
- David C. Habiger seat on Boston Scientific, effective 2024-01-01.
- Audit; Executive Compensation and Human Resources committee of Boston Scientific, effective 2024-01-01.
- David C. Habiger member of Audit; Executive Compensation and Human Resources, effective 2024-01-01.
- Executive Compensation and Human Resources; Risk, Science and Technology · Chair committee of Boston Scientific, effective 2024-01-01.
- Cheryl Pegus member of Executive Compensation and Human Resources; Risk, Science and Technology · Chair, effective 2024-01-01.
- Jessica L. Mega seat on Boston Scientific, effective 2023-01-01.
- Susan E. Morano seat on Boston Scientific, effective 2023-01-01.
- Audit; Nominating and Governance · Chair committee of Boston Scientific, effective 2023-01-01.
- Susan E. Morano member of Audit; Nominating and Governance · Chair, effective 2023-01-01.
- Jessica L. Mega member of Executive Compensation and Human Resources; Risk, Science and Technology, effective 2023-01-01.
- David S. Wichmann seat on Boston Scientific, effective 2021-01-01.
- Audit · Chair; Risk, Science and Technology committee of Boston Scientific, effective 2021-01-01.
- David S. Wichmann member of Audit · Chair; Risk, Science and Technology, effective 2021-01-01.
- Ellen M. Zane seat on Boston Scientific, effective 2016-01-01.
- Executive Compensation and Human Resources · Chair; Nominating and Governance committee of Boston Scientific, effective 2016-01-01.
- Ellen M. Zane member of Executive Compensation and Human Resources · Chair; Nominating and Governance, effective 2016-01-01.
- Eric Ludwig seat on Boston Scientific, effective 2014-01-01.
- Eric Ludwig lead independent director of Boston Scientific, effective 2014-01-01.
- Eric Ludwig member of Audit; Nominating and Governance, effective 2014-01-01.
- Michael F. Mahoney seat on Boston Scientific, effective 2012-01-01.

